Camrelizumab Combined With Apatinib in the Treatment of Patients With Advanced Gastric Cancer and Colorectal Cancer

NCT04067986 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Recurrent

Interventions

DRUG: Camrelizumab
DRUG: Apatinib

Sponsor

Zhongshan Hospital Xiamen University